已收录 268921 条政策
 政策提纲
  • 暂无提纲
Cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab maintenance treatment
[摘要] A 47-year-old male with paroxysmal nocturnal haemoglobinuria (PNH) controlled with routine ravulizumab administration suffered a massive haemolytic crisis due to choledocholithiasis. Laparoscopic cholecystectomy was performed 6 weeks after a regular ravulizumab infusion. After surgery, the patient presented with anaemia without marked elevation in lactate dehydrogenase and required two blood transfusions. Tumour necrosis factor- α increased more than twofold with reticulocyte suppression after surgery, suggesting the involvement of myelosuppressive cytokines. This case suggests that laparoscopic surgery may be safely performed in patients with PNH receiving ravulizumab maintenance treatment. However, attention should be paid to postoperative anaemia, regardless of breakthrough haemolysis.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词] cholecystectomy;paroxysmal nocturnal haemoglobinuria;ravulizumab;tumour necrosis factor-α [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文